Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease hepatitis
Phenotype |hepatocellular carcinoma
Sentences 268
PubMedID- 21157144 A 57-yr-old female patient with hepatocellular carcinoma due to hepatitis c virus received a liver transplantation.
PubMedID- 23615731 A tissue microarray containing hepatocellular carcinoma samples with hepatitis b-positive patients (50 cases, 2 cores per case) and two non-neoplastic liver samples (2 cores per sample) was purchased from accumax (a217).
PubMedID- 24707821 Both multi-tgdr frameworks were used to analyze a metabolomics dataset that compares the metabolic profiles of hepatocellular carcinoma (hcc) infected with hepatitis b (hbv) or c virus (hcv) with that of cirrhosis induced by hbv/hcv infection; the goal was to improve early-stage diagnosis of hcc.
PubMedID- 21766498 Purpose: the aim of this study was to compare patients with hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection with patients with liver cirrhosis associated with hcv virus infection.
PubMedID- 21133598 Comparison of serum survivin and alpha fetoprotein in egyptian patients with hepatocellular carcinoma associated with hepatitis c viral infection.
PubMedID- 24462733 A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis c and cirrhosis.
PubMedID- 25478255 A 62-year-old woman, with cirrhosis due to hepatitis b associated with hepatocellular carcinoma, was submitted to living donor liver transplantation.
PubMedID- 20495329 [a case of hepatocellular carcinoma with autoimmune hepatitis showing marked reduction of tumors by oral administration of uft-e].
PubMedID- 25559606 The effect of hiv viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis c and hiv coinfection.
PubMedID- 24020023 Indications for living-donor liver transplantation in these patients were hepatitis b cirrhosis with hepatocellular carcinoma (n = 8), hepatitis b cirrhosis without hepatocellular carcinoma (n = 3), autoimmune disease (n = 1), and wilson's disease (n = 2).
PubMedID- 24918150 Antiviral therapy is not enough to prevent hepatocellular carcinoma development in patients with chronic hepatitis b.
PubMedID- 26469163 Methods: thirty consecutive cases of percutaneous arterial chemoembolization for hepatocellular carcinoma with hepatitis c-related cirrhosis(male, 23; female, 7; age, 74+/-5.9; weight, 62.7+/-12.3 kg; child-pugh a, 23; child-pugh b, 7)were analyzed retrospectively.
PubMedID- 24405714 [41] showed that the expression level of mir-122 continues to decrease in hepatocellular carcinoma with chronic hepatitis b viral infection compared with preoperative and healthy people.
PubMedID- 22221966 hepatocellular carcinoma and survival in patients with autoimmune hepatitis (japanese national hospital organization-autoimmune hepatitis prospective study).
PubMedID- 24130799 Despite this, several studies hint at differences in expression of mir-122, a liver-specific microrna with tumor suppressor properties, in hepatocellular carcinoma (hcc) associated with hepatitis b virus (hbv) versus hepatitis c virus (hcv) infection.
PubMedID- 20549250 Laparoscopic findings of reddish markings predict hepatocellular carcinoma in patients with hepatitis b virus-related liver disease.
PubMedID- 24312130 To investigate whether killer cell immunoglobulin-like receptor (kir) and human leukocyte antigen (hla) genetic background could influence the onset age of hepatocellular carcinoma (hcc) in patients with hepatitis b virus (hbv) infection, one hundred and seventy-one males with hbv-related hcc were enrolled.
PubMedID- 25735064 A 65-year-old woman had previously undergone ldlt for hepatocellular carcinoma associated with hepatitis b virus infection.
PubMedID- 20883676 Background: there are few blood tests for an efficient detection of hepatocellular carcinoma (hcc) associated with hepatitis c virus (hcv) infection.
PubMedID- 23781497 Evaluated the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection and found that the c > t polymorphisms at foki position in the vdr gene served as a potential biomarker for the risk and the disease severity of hcc in those infected with hbv.
PubMedID- 26159441 Background: this study was designed to evaluate the prognostic value of three systemic inflammation markers, neutrophil to lymphocyte ratio (nlr), platelet to lymphocyte ratio (plr), and prognostic nutritional index (pni), for hepatocellular carcinoma (hcc) associated with hepatitis b (hbv).
PubMedID- 23849467 The present cross-sectional study investigated 12 perfluoroalkyl substances (pfass) in serum (n=79) and liver (n=66) samples from patients who had undergone liver transplantation for a range of conditions, such as hepatocellular carcinoma (hcc), cirrhosis due to chronic hepatitis c viral infection (hcv), both hcc and hcv, amyloidosis or acute liver failure.
PubMedID- 25082726 Although the development of hepatocellular carcinoma following infection with hepatitis virus is a crucial health problem, there are few reports of hemophilia patients undergoing liver resection for hepatocellular carcinoma.
PubMedID- 21196168 Immunization practices and the use of potent antiviral therapy may have a major impact in reducing the burden of chronic liver disease and the incidence of hepatocellular carcinoma associated with chronic hepatitis b and chronic hepatitis d.
PubMedID- 26017875 Alterations of wnt/beta-catenin signaling pathway in hepatocellular carcinomas associated with hepatitis c virus.
PubMedID- 23691458 Found increased mir-196a expression among hepatocellular carcinoma patients with hepatitis b virus infection who carried the c allele [22].
PubMedID- 21573177 Upon hcv infection, up to 80% individuals will develop persistent viraemia and chronic hepatitis, which potentially leads to liver cirrhosis, hepatocellular carcinoma, end-stage liver disease, and liver failure [2].
PubMedID- 22118340 The chb natural history influenced density of tumour-infiltrating tregs in hepatocellular carcinoma patients with chronic hepatitis b viruses infection.
PubMedID- 21170963 Obesity and metabolic syndrome are recognized risk factors for development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc).
PubMedID- 24696192 Prediction of hepatocellular carcinoma recurrence in patients with low hepatitis b virus dna levels and high preoperative hepatitis b surface antigen levels.
PubMedID- 23202460 Glycyrrhizin, for instance, a component of licorice roots extract, has been shown to prevent the development of hepatocellular carcinoma in patients with chronic hepatitis [110].
PubMedID- 22419005 Does antiviral therapy reduce the risk of hepatocellular carcinoma in patients with chronic hepatitis c.
PubMedID- 21998681 Kir and hla loci are associated with hepatocellular carcinoma development in patients with hepatitis b virus infection: a case-control study.
PubMedID- 23564522 The effects of interferon (ifn) treatment and the post-ifn treatment alpha-fetoprotein (afp) levels on risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc) are unknown.
PubMedID- 25803433 Tsan et al used this definition to study statins and the risk of hepatocellular carcinoma in patients with hepatitis b virus infection [24].
PubMedID- 24677195 hepatocellular carcinoma screening in patients with compensated hepatitis c virus (hcv)-related cirrhosis aware of their hcv status improves survival: a modeling approach.
PubMedID- 24055508 Background & aims: hepatocellular carcinoma develops in patients with chronic hepatitis or cirrhosis via a stepwise accumulation of various genetic alterations.
PubMedID- 21461077 Background/aims: despite great progress, antiviral treatment for chronic hepatitis c in patients with prior hepatocellular carcinoma (hcc) has been rarely investigated.
PubMedID- 22879825 hepatocellular carcinoma complicates 5% of the chronic hepatitis c cases [1][2].
PubMedID- 21537363 A 78-year-old male who experienced multiple recurrences of hepatocellular carcinoma (hcc) with hepatitis c virus (hcv)-related cirrhosis underwent transcatheter arterial chemoembolization and ablation and survived for more than 10 years.
PubMedID- 25912838 We assessed the effects of hvpg and svr on the risk of liver decompensation, hepatocellular carcinoma, and/or death in patients with hepatitis c-related cirrhosis.
PubMedID- 23586065 To evaluate the possible association between the vitamin d receptor (vdr), single-nucleotide polymorphisms (snps), and hepatocellular carcinoma (hcc) in patients with chronic hepatitis b virus (hbv) infection.
PubMedID- 24876745 Several studies have been carried out to create risk calculators for the prediction of hepatocellular carcinoma (hcc) in patients with chronic hepatitis b (chb).
PubMedID- 26045707 Conclusions: sustained virological response can reduce all-cause mortality and the incidence of hepatocellular carcinoma of patients with hepatitis c.
PubMedID- 24595492 We describe a case of a 62-year-old diabetic woman with hepatocellular carcinoma due to chronic hepatitis b virus infection.
PubMedID- 21859997 Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis b and c.
PubMedID- 22659345 Polymorphisms of dna repair genes in korean hepatocellular carcinoma patients with chronic hepatitis b: possible implications on survival.
PubMedID- 21319289 Second neoplasms appeared in 3 patients, 1 of whom died of hepatocellular carcinoma following infection with hepatitis b.
PubMedID- 23509319 Statins and the risk of hepatocellular carcinoma in patients with hepatitis c virus infection.
PubMedID- 21160825 Skull metastasis from hepatocellular carcinoma with chronic hepatitis b.

Page: 1 2 3 4 5 6